Join to view full profile
1475 NW 12th AveMiami, FL 33136
Phone+1 305-243-5302
Fax+1 954-210-1085
Dr. Ikpeazu is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1998 - 2000
East Tennessee State University/Quillen College of MedicineFellowship, Hematology and Medical Oncology, 1996 - 1998
Meharry Medical CollegeResidency, Internal Medicine, 1994 - 1996
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1992 - 1994- Meharry Medical CollegeClass of 1992
Certifications & Licensure
FL State Medical License 2007 - 2028
TN State Medical License 1995 - 2013
MN State Medical License 1993 - 1995
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2017
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma Start of enrollment: 2013 Jun 03
Publications & Presentations
PubMed
- Molecular Profiling and Real-world Outcomes of BRAF V600E-Mutated Papillary Thyroid Cancer.Martina Chirra, Andrew Elliott, Hira Shaikh, Julie McGrath, Dalia El-Gamal
Clinical Cancer Research. 2026-03-16 - 10 citationsLong-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus-Initiat...Barbara Burtness, Yael Flamand, Harry Quon, Gregory S Weinstein, Ranee Mehra
Journal of Clinical Oncology. 2025-08-10 - 4 citationsNeoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163.Nabil F Saba, Yael Flamand, Derrick T Lin, Christine H Chung, Mark W McDonald
Clinical Cancer Research. 2025-06-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
